Affiliations
AffiliationsItem in Clipboard
Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based PopulationTheodore R Levin et al. Gastroenterology. 2018 Nov.
. 2018 Nov;155(5):1383-1391.e5. doi: 10.1053/j.gastro.2018.07.017. Epub 2018 Jul 19. Authors Theodore R Levin 1 , Douglas A Corley 2 , Christopher D Jensen 2 , Joanne E Schottinger 3 , Virginia P Quinn 3 , Ann G Zauber 4 , Jeffrey K Lee 2 , Wei K Zhao 2 , Natalia Udaltsova 2 , Nirupa R Ghai 3 , Alexander T Lee 3 , Charles P Quesenberry 2 , Bruce H Fireman 2 , Chyke A Doubeni 5 AffiliationsItem in Clipboard
AbstractBackground & aims: Little information is available on the effectiveness of organized colorectal cancer (CRC) screening on screening uptake, incidence, and mortality in community-based populations.
Methods: We contrasted screening rates, age-adjusted annual CRC incidence, and incidence-based mortality rates before (baseline year 2000) and after (through 2015) implementation of organized screening outreach, from 2007 through 2008 (primarily annual fecal immunochemical testing and colonoscopy), in a large community-based population. Among screening-eligible individuals 51-75 years old, we calculated annual up-to-date status for cancer screening (by fecal test, sigmoidoscopy, or colonoscopy), CRC incidence, cancer stage distributions, and incidence-based mortality.
Results: Initiation of organized CRC screening significantly increased the up-to-date status of screening, from 38.9% in 2000 to 82.7% in 2015 (P < .01). Higher rates of screening were associated with a 25.5% reduction in annual CRC incidence between 2000 and 2015, from 95.8 to 71.4 cases/100,000 (P < .01), and a 52.4% reduction in cancer mortality, from 30.9 to 14.7 deaths/100,000 (P < .01). Increased screening was initially associated with increased CRC incidence, due largely to greater detection of early-stage cancers, followed by decreases in cancer incidence. Advanced-stage CRC incidence rates decreased 36.2%, from 45.9 to 29.3 cases/100,000 (P < .01), and early-stage CRC incidence rates decreased 14.5%, from 48.2 to 41.2 cases/100,000 (P < .04).
Conclusions: Implementing an organized CRC screening program in a large community-based population rapidly increased screening participation to the ≥80% target set by national organizations. Screening rates were sustainable and associated with substantial decreases in CRC incidence and mortality within short time intervals, consistent with early detection and cancer prevention.
Keywords: Colon Cancer; Early Detection; FIT; Neoplasm.
Copyright © 2018 AGA Institute. Published by Elsevier Inc. All rights reserved.
Conflict of interest statementDisclosures: No conflicts of interest exist for any of the authors.
FiguresFigure 1.
Percentage of Eligible Cohort Members…
Figure 1.
Percentage of Eligible Cohort Members Screening Up-to-Date: Overall and by Modality.
Figure 1.Percentage of Eligible Cohort Members Screening Up-to-Date: Overall and by Modality.
Figure 2.
Cohort Age-Adjusted Colorectal Cancer (CRC)…
Figure 2.
Cohort Age-Adjusted Colorectal Cancer (CRC) Incidence Rates and Incidence-Based Mortality Rates: Age-Adjusted to…
Figure 2.Cohort Age-Adjusted Colorectal Cancer (CRC) Incidence Rates and Incidence-Based Mortality Rates: Age-Adjusted to the United States 2000 Census Population.
Figure 3:
Cohort Colorectal Cancer (CRC) Incidence…
Figure 3:
Cohort Colorectal Cancer (CRC) Incidence Rates by Stage: Age-Adjusted to the United States…
Figure 3:Cohort Colorectal Cancer (CRC) Incidence Rates by Stage: Age-Adjusted to the United States 2000 Census Population.
Similar articlesvan der Vlugt M, Grobbee EJ, Bossuyt PMM, Bos A, Bongers E, Spijker W, Kuipers EJ, Lansdorp-Vogelaar I, Spaander MCW, Dekker E. van der Vlugt M, et al. Gastroenterology. 2017 Aug;153(2):439-447.e2. doi: 10.1053/j.gastro.2017.05.004. Epub 2017 May 5. Gastroenterology. 2017. PMID: 28483499
D'Andrea E, Ahnen DJ, Sussman DA, Najafzadeh M. D'Andrea E, et al. Cancer Med. 2020 Jan;9(2):824-836. doi: 10.1002/cam4.2735. Epub 2019 Nov 28. Cancer Med. 2020. PMID: 31777197 Free PMC article.
Saito H, Kudo SE, Takahashi N, Yamamoto S, Kodama K, Nagata K, Mizota Y, Ishida F, Ohashi Y. Saito H, et al. Int J Colorectal Dis. 2020 May;35(5):933-939. doi: 10.1007/s00384-020-03518-w. Epub 2020 Feb 7. Int J Colorectal Dis. 2020. PMID: 32034490 Clinical Trial.
Brenner H, Hoffmeister M. Brenner H, et al. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014 Mar;57(3):302-6. doi: 10.1007/s00103-013-1911-2. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2014. PMID: 24562704 Review. German.
Zavoral M, Suchanek S, Majek O, Fric P, Minarikova P, Minarik M, Seifert B, Dusek L. Zavoral M, et al. World J Gastroenterol. 2014 Apr 14;20(14):3825-34. doi: 10.3748/wjg.v20.i14.3825. World J Gastroenterol. 2014. PMID: 24744575 Free PMC article. Review.
Sharma GG, Okada Y, Von Hoff D, Goel A. Sharma GG, et al. Semin Cancer Biol. 2021 Oct;75:153-168. doi: 10.1016/j.semcancer.2020.10.001. Epub 2020 Oct 10. Semin Cancer Biol. 2021. PMID: 33049362 Free PMC article. Review.
Liao C, Gong Z, Fang R, Li L, Gao Z, Mao M, Zeng L. Liao C, et al. PLoS One. 2024 Oct 10;19(10):e0309334. doi: 10.1371/journal.pone.0309334. eCollection 2024. PLoS One. 2024. PMID: 39388425 Free PMC article.
Chen C, Stock C, Hoffmeister M, Brenner H. Chen C, et al. Clin Transl Gastroenterol. 2020 Oct;11(10):e00243. doi: 10.14309/ctg.0000000000000243. Clin Transl Gastroenterol. 2020. PMID: 33031193 Free PMC article.
Gupta S, Lieberman D. Gupta S, et al. Gastroenterology. 2020 Oct;159(4):1205-1208. doi: 10.1053/j.gastro.2020.06.091. Epub 2020 Jul 16. Gastroenterology. 2020. PMID: 32682766 Free PMC article. No abstract available.
Zwager LW, Moons LMG, Farina Sarasqueta A, Laclé MM, Albers SC, Hompes R, Peeters KCMJ, Bekkering FC, Boonstra JJ, Ter Borg F, Bos PR, Bulte GJ, Gielisse EAR, Hazen WL, Ten Hove WR, Houben MHMG, Mundt MW, Nagengast WB, Perk LE, Quispel R, Rietdijk ST, Rando Munoz FJ, de Ridder RJJ, Schwartz MP, Schreuder RM, Seerden TCJ, van der Sluis H, van der Spek BW, Straathof JWA, Terhaar Sive Droste JS, Vlug MS, van de Vrie W, Weusten BLAM, de Wijkerslooth TD, Wolters HJ, Fockens P, Dekker E, Bastiaansen BAJ; the Dutch eFTR Working Group. Zwager LW, et al. BMC Gastroenterol. 2022 Dec 13;22(1):516. doi: 10.1186/s12876-022-02591-5. BMC Gastroenterol. 2022. PMID: 36513968 Free PMC article.
RetroSearch is an open source project built by @garambo | Open a GitHub Issue
Search and Browse the WWW like it's 1997 | Search results from DuckDuckGo
HTML:
3.2
| Encoding:
UTF-8
| Version:
0.7.3